Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.8.0.1
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2017
Investments, Debt and Equity Securities [Abstract]  
Cash and Cash Equivalents
Cash and financial instruments measured and recorded at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 are summarized below:
 
September 30, 2017
 
December 31, 2016
 
(In millions)
Cash
$
118

 
$
67

Level 1(1) (2)
 
 
 
Government money market funds
$
115

 
$
50

Total level 1
$
115

 
$
50

Level 2(1) (3)
 
 
 
Commercial paper
$
646

 
$
1,147

Total level 2
$
646

 
$
1,147

Total
$
879

 
$
1,264



(1) 
The Company did not have any transfers between Level 1 and Level 2 of the fair value hierarchy during the quarter and nine months ended September 30, 2017 or the year ended December 31, 2016.
(2) 
The Company's Level 1 assets are valued using quoted prices for identical instruments in active markets.
(3) 
The Company’s Level 2 assets are valued using broker reports that utilize quoted market prices for identical or comparable instruments. Brokers gather observable inputs for all of the Company’s fixed income securities from a variety of industry data providers and other third-party sources.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
The carrying amounts and estimated fair values of financial instruments not recorded at fair value are as follows:
 
September 30, 2017
 
December 31, 2016
 
Carrying
Amount
 
Estimated
Fair Value
 
Carrying
Amount
 
Estimated
Fair Value
 
(In millions)
Short-term debt
$
70

 
$
70

 
$

 
$

Long-term debt, net(1)
$
1,355

 
$
2,294

 
$
1,434

 
$
2,313



(1)
Carrying amounts of long-term debt are net of unamortized debt issuance costs of $21 million as of September 30, 2017 and $25 million as of December 31, 2016, based on the adoption of ASU 2015-03 and net of unamortized debt discount associated with the 2.125% Notes of $291 million as of September 30, 2017 and $308 million as of December 31, 2016.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations
The following table shows the amount of gain (loss) included in accumulated other comprehensive gain (loss) and the amount of gain (loss) reclassified from accumulated other comprehensive gain (loss) and included in earnings related to the foreign currency forward contracts designated as cash flow hedges:
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2017
 
September 24,
2016
 
September 30,
2017
 
September 24,
2016
 
(In millions)
Foreign Currency Forward Contracts - gains (losses)
 
 
 
 
 
 
 
Contracts designated as cash flow hedging instruments
 
 
 
 
 
 
 
Other comprehensive income (loss)
$
1

 
$
(1
)
 
$
8

 
$
7

Research and development
3

 
1

 
4

 

Marketing, general and administrative
1

 

 
1

 

Contracts not designated as hedging instruments
 
 
 
 
 
 
 
Other income (expense), net
$
(2
)
 
$

 
$
(3
)
 
$
2

Schedule of Fair Value Amounts of Foreign Currency Forward Contracts in Balance Sheet
The following table shows the fair value amounts included in Other current assets should the foreign currency forward contracts be in a gain position or included in Other current liabilities should these contracts be in a loss position. These amounts were recorded in the Company's condensed consolidated balance sheets as follows:
 
September 30,
2017
 
December 31,
2016
 
(In millions)
Foreign Currency Forward Contracts - gains (losses)
 
 
 
Contracts designated as cash flow hedging instruments
$
6

 
$
(2
)